Are AI Rings False Demand? Oura's IPO Plan and Accuracy Lawsuit
As Oura seeks a $50B+ U.S. IPO valuation, a class-action suit over sleep accuracy exposes the gap between capital hype and product reality.
As Oura seeks a $50B+ U.S. IPO valuation, a class-action suit over sleep accuracy exposes the gap between capital hype and product reality.
FDA and lettuce supplier Taylor Farms clash over cyclosporiasis outbreak. Behind the spat over the FDA's "apology" interpretation lie challenges in food testing technology.
Samsung has informed users in the US that it will discontinue the Galaxy Watch's Vascular Load feature. While the reason remains undisclosed, FDA regulations may be a factor. A Blood Pressure Trend feature is expected to be introduced as an alternative.
FDA advisory committee votes 9-0 to support approval of Moderna’s mRNA seasonal flu vaccine mRNA-1010 (mFlusiva), showing 27% higher efficacy than standard vaccines, after turmoil over Trump appointee’s initial rejection.
This site uses cookies for access analysis and ad delivery. By clicking "Accept", you consent to the use of cookies. See our Privacy Policy for details.